As of November 19, 2009 , 16 countries,
more than 65 million Dose vaccines are given ; A strong immune
response against the disease that the vaccine is safe and effective,
so that the product is. The current trivalent seasonal influenza
vaccine H1N1 increases nor decreases the risk of infection , because
the pandemic strain vaccine is quite different from the strains used.
Overall, the safety profile of the new
H1N1 vaccine is considered the same as the seasonal flu vaccine and
vaccination, fewer than a dozen cases of the syndrome have
Postencephalitic. Viruses for the vaccine are grown in chicken-egg
-based cultures are safety concerns for people who are allergic to
eggs .
After consultation with their physician
if they are allergic to eggs in a careful and controlled environment
Dose take a few amounts. By the end of November in Canada,
anaphylactic shock following vaccination, 24 people have been
infected with, one death. Over 312,000 people have taken the vaccine
is 1 anaphylactic reaction.
No comments:
Post a Comment